Literature DB >> 22290966

Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients.

Nicolas Charhon1, Michael N Neely, Laurent Bourguignon, Pascal Maire, Roger W Jelliffe, Sylvain Goutelle.   

Abstract

Most aminoglycoside pharmacokinetic models include an index of renal function, such as creatinine clearance, to describe drug clearance. However, the best clinical descriptor of renal function for the pharmacokinetic modeling of aminoglycosides has not been established. This analysis was based on 412 gentamicin concentrations from 92 geriatric patients who received intravenous gentamicin for various infectious diseases. Four two-compartment population models were fitted to gentamicin concentrations in a learning set of 64 patients using the nonparametric adaptive grid (NPAG) algorithm. Each model included an index of renal function, namely, the Cockcroft-Gault (CG), Jelliffe (JEL), modification of diet in renal disease (MDRD), or modified MDRD (MDRDm; adjusted to individual body surface area) equation as a covariate influencing gentamicin serum clearance. Goodness of fit and predictive performance of the four models were compared using standard criteria in both the learning set and in a validation set of 28 patients. A final analysis was performed to estimate the population pharmacokinetic parameter values of the entire 92-patient group. In the learning set, the CG-based model best fit the data, followed by JEL-, MDRD-, and MDRDm-based models, with relative reductions of the Akaike information criterion of 29.4, 20.2, 14.2, and 4.2, respectively. Bias and precision of population predictions were significantly different among the four models. In the validation set, individual predictions from the four models showed marginally different biases. The final estimation confirmed the previous results. Specifically, the CG-based model showed predictive performance that was comparable to or better than that of the MDRD-based model at each stage of the analysis. This study shows that methods used to estimate renal function should not be considered interchangeable for the model-based estimation of gentamicin concentrations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290966      PMCID: PMC3318363          DOI: 10.1128/AAC.05634-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 2.  Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies.

Authors:  R W Jelliffe; T Iglesias; A K Hurst; K A Foo; J Rodriguez
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

3.  Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.

Authors:  C M Kirkpatrick; S B Duffull; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 4.  Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.

Authors:  R W Jelliffe; A Schumitzky; D Bayard; M Milman; M Van Guilder; X Wang; F Jiang; X Barbaut; P Maire
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

5.  Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm.

Authors:  J Debord; J P Charmes; P Marquet; L Merle; G Lachâtre
Journal:  Int J Clin Pharmacol Ther       Date:  1997-01       Impact factor: 1.366

6.  Use of GFR equations to adjust drug doses in an elderly multi-ethnic group--a cautionary tale.

Authors:  Jagbir Gill; Rhonda Malyuk; Ognjenka Djurdjev; Adeera Levin
Journal:  Nephrol Dial Transplant       Date:  2007-06-16       Impact factor: 5.992

7.  Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.

Authors:  P Brandon Bookstaver; James W Johnson; Thomas P McCoy; David Stewart; John C Williamson
Journal:  Ann Pharmacother       Date:  2008-12       Impact factor: 3.154

Review 8.  Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups.

Authors:  W E Dager
Journal:  Ann Pharmacother       Date:  1994 Jul-Aug       Impact factor: 3.154

Review 9.  Aminoglycosides--50 years on.

Authors:  E J Begg; M L Barclay
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

10.  [Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight].

Authors:  Laurent Bourguignon; Sylvain Goutelle; Cécile Gérard; Anne Guillermet; Julie Burdin de Saint Martin; Pascal Maire; Michel Ducher
Journal:  Therapie       Date:  2009-05-26       Impact factor: 2.070

View more
  10 in total

1.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

2.  Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance.

Authors:  Maria-Eugenia Palacio-Lacambra; Immaculada Comas-Reixach; Albert Blanco-Grau; Josep-Maria Suñé-Negre; Alfonso Segarra-Medrano; José-Bruno Montoro-Ronsano
Journal:  Br J Clin Pharmacol       Date:  2018-07-08       Impact factor: 4.335

3.  Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients.

Authors:  Anaïs Glatard; Laurent Bourguignon; Roger W Jelliffe; Pascal Maire; Michael N Neely; Sylvain Goutelle
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

Review 4.  Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.

Authors:  Alexandre Boyer; Didier Gruson; Stéphane Bouchet; Benjamin Clouzeau; Bui Hoang-Nam; Frédéric Vargas; Hilbert Gilles; Mathieu Molimard; Anne-Marie Rogues; Nicholas Moore
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

5.  New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients.

Authors:  A Åsberg; A Bjerre; M Neely
Journal:  Pediatr Transplant       Date:  2013-10-23

6.  Predictive performance of gentamicin dosing nomograms.

Authors:  Jieon Lee; Seonghae Yoon; Donghoon Shin; HyeKyung Han; Hyungmi An; Jongtae Lee; Kyoung Soo Lim; Kyung-Sang Yu; Howard Lee
Journal:  Drug Des Devel Ther       Date:  2014-08-16       Impact factor: 4.162

7.  Predictive Value of Creatinine-based Equations of Kidney Function in the Long-term Prognosis in United Arab Emirates Patients.

Authors:  Saif Al-Shamsi; Romona D Govender; Jeffrey King
Journal:  Oman Med J       Date:  2021-01-21

8.  Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration.

Authors:  Daniel J Selig; Kevin S Akers; Kevin K Chung; Kaitlin A Pruskowski; Jeffrey R Livezey; Elaine D Por
Journal:  Br J Clin Pharmacol       Date:  2021-12-09       Impact factor: 3.716

9.  Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly.

Authors:  Anders Helldén; Ingegerd Odar-Cederlöf; Göran Nilsson; Susanne Sjöviker; Anders Söderström; Mia von Euler; Gunnar Ohlén; Ulf Bergman
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

10.  Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.

Authors:  Elaine D Por; Kevin S Akers; Kevin K Chung; Jeffrey R Livezey; Daniel J Selig
Journal:  J Clin Pharmacol       Date:  2021-06-19       Impact factor: 3.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.